Literature DB >> 20544678

Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.

Asaad A Ghanem1, Ahmed Elewa, Lamiaa F Arafa.   

Abstract

PURPOSE: Advanced glycation end products (AGEs) accumulation may result from chronic hyperglycemia promoting generation and onset of microangiopathy. The aim of this study was to investigate the association between diabetic retinopathy (DR) and levels of AGEs, pentosidine, and N-carboxymethyl-lysine (CML) in aqueous humor and serum of human patients and their role in predicting the progression of DR.
METHODS: Ninety patients with type 2 diabetes mellitus and 30 nondiabetic patients underwent cataract surgery. The diabetic group was divided into 3 subgroups: 35 patients with mild nonproliferative diabetic retinopathy (mild NPDR), 30 patients with severe nonproliferative diabetic retinopathy (severe NPDR), and 25 patients with proliferative diabetic retinopathy (PDR). In the samples, pentosidine was measured by high-performance liquid chromatography and CML using a competitive enzyme-linked immunosorbent assay.
RESULTS: Serum levels of pentosidine and CML were significantly increased in patients with type 2 diabetes compared to nondiabetic controls (p<0.001). In diabetic patients, serum pentosidine and CML levels were significantly higher in patients who had PDR than in those with mild NPDR or severe NPDR (both p<0.001). A significant difference was found between aqueous humor CML levels in diabetic and nondiabetic patients and increased along with progression of DR. Significant correlations existed between serum pentosidine and aqueous CML in severe NPDR and PDR (p<0.001).
CONCLUSIONS: In patients with type 2 DM, serum levels of pentosidine and CML are related to severity of retinopathy. In addition, aqueous humor level of CML increased along with progression of DR. Pentosidine and CML can be used as biochemical markers of glycoxidation and related to onset or progression of DR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20544678     DOI: 10.5301/ejo.2010.4447

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  19 in total

Review 1.  Dietary Advanced Glycation End Products and Cardiometabolic Risk.

Authors:  Claudia Luévano-Contreras; Armando Gómez-Ojeda; Maciste Habacuc Macías-Cervantes; Ma Eugenia Garay-Sevilla
Journal:  Curr Diab Rep       Date:  2017-08       Impact factor: 4.810

2.  Morphological Changes and Immunohistochemical Expression of RAGE and its Ligands in the Sciatic Nerve of Hyperglycemic Pig (Sus Scrofa).

Authors:  Judyta K Juranek; Alexey Aleshin; Eileen M Rattigan; Lynne Johnson; Wu Qu; Fei Song; Radha Ananthakrishnan; Nosirudeen Quadri; Shi Du Yan; Ravichandran Ramasamy; Ann Marie Schmidt; Matthew S Geddis
Journal:  Biochem Insights       Date:  2010-09-01

3.  Houttuynia cordata aqueous extract attenuated glycative and oxidative stress in heart and kidney of diabetic mice.

Authors:  Cheng-Chin Hsu; Hui-Ting Yang; Jing-Jing Ho; Mei-Chin Yin; Jen-Ying Hsu
Journal:  Eur J Nutr       Date:  2015-07-22       Impact factor: 5.614

Review 4.  Advanced glycation endproducts: from precursors to RAGE: round and round we go.

Authors:  Ravichandran Ramasamy; Shi Fang Yan; Ann Marie Schmidt
Journal:  Amino Acids       Date:  2010-10-19       Impact factor: 3.520

Review 5.  Biomarkers in diabetic nephropathy: Present and future.

Authors:  Gemma Currie; Gerard McKay; Christian Delles
Journal:  World J Diabetes       Date:  2014-12-15

6.  Curcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPARγ activity and attenuating oxidative stress.

Authors:  Jianguo Lin; Youcai Tang; Qiaohua Kang; Yunfeng Feng; Anping Chen
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

7.  Hyperglycaemia cause vascular inflammation through advanced glycation end products/early growth response-1 axis in gestational diabetes mellitus.

Authors:  Barathi Rajaraman; Nirupama Ramadas; Sundar Krishnasamy; Vidya Ravi; Atima Pathak; C S Devasena; Krishnan Swaminathan; Arunkumar Ganeshprasad; Ashok Ayyappa Kuppuswamy; Srinivasan Vedantham
Journal:  Mol Cell Biochem       Date:  2019-02-14       Impact factor: 3.396

8.  Curcumin eliminates the inhibitory effect of advanced glycation end-products (AGEs) on gene expression of AGE receptor-1 in hepatic stellate cells in vitro.

Authors:  Jianguo Lin; Youcai Tang; Qiaohua Kang; Anping Chen
Journal:  Lab Invest       Date:  2012-03-26       Impact factor: 5.662

9.  Development and Application of Mass Spectroscopy Assays for Nε-(1-Carboxymethyl)-L-Lysine and Pentosidine in Renal Failure and Diabetes.

Authors:  Katherine L O'Grady; Sundeep Khosla; Joshua N Farr; Olga P Bondar; Elizabeth J Atkinson; Sara J Achenbach; Brittany A Eckhardt; Brianne S Thicke; Amanda J Tweed; Tammie L Volkman; Matthew T Drake; Jolaine M Hines; Ravinder J Singh
Journal:  J Appl Lab Med       Date:  2020-05-01

10.  Association of dietary intake, medication and anthropometric indices with serum levels of advanced glycation end products, caspase-3, and matrix metalloproteinase-9 in diabetic patients.

Authors:  Elaheh Foroumandi; Sorayya Kheirouri; Rahmat Nosrati; Ramin Ghodsi
Journal:  J Diabetes Metab Disord       Date:  2021-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.